Watchlist Price Alert

Kalaris Therapeutics Inc (KLRS)

NASDAQ: KLRS · Real-Time Price · USD

2.58

0.02 (0.78%)

At close: Jun 27, 2025, 3:59 PM

2.52

-2.51%

After-hours: Jun 27, 2025, 07:01 PM EDT

Kalaris Therapeutics Inc Cash Flow Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q4 2023
Period Ending	Dec 31, 2023
Net Income	-3.47M
Depreciation & Amortization	n/a
Stock-Based Compensation	31K
Other Working Capital	-1.31M
Other Non-Cash Items	105K
Deferred Income Tax	n/a
Change in Working Capital	-801K
Operating Cash Flow	-4.14M
Capital Expenditures	n/a
Cash Acquisitions	n/a
Purchase of Investments	n/a
Sales Maturities Of Investments	n/a
Other Investing Acitivies	n/a
Investing Cash Flow	n/a
Debt Repayment	n/a
Common Stock Repurchased	n/a
Dividend Paid	n/a
Other Financial Acitivies	117K
Financial Cash Flow	6.86M
Net Cash Flow	2.72M
Free Cash Flow	-4.14M